SCHEMBL23486578

SCHEMBL23486578

C/C(=C\c1ccc(Nc2c(C(=O)O)noc2C)cc1)c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ BRD4 O60885 1/20 0.37
▸ BRD2 P25440 1/20 0.37
▸ KMT2A Q03164 5/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ CYP2C19 P33261 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ APEX1 P27695 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609283 0.79 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL22609257 0.79 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL22609213 0.79 ALDH1A1 (0.38) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL23453731 0.73 RAPGEF4 (0.41) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL22609268 0.70 DHODH (0.43) ALDH1A1LMNAHSD17B10ALOX15SMN1; SMN2
SCHEMBL22609335 0.68 HTT (0.45) KMT2AMEN1ALDH1A1LMNANPC1
SCHEMBL22609248 0.68 ALDH1A1 (0.38) KMT2AMEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL22609253 0.68 ALDH1A1 (0.52) KMT2AALDH1A1SMN1; SMN2ATMPOLB
SCHEMBL27627423 0.68 LMNA (0.46) KMT2AMEN1ALDH1A1LMNATSHR
SCHEMBL23453717 0.68 DHODH (0.41) ALDH1A1CYP2C19HSD17B10ALOX15PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS PTGS2 553/4885ALOX5 69/4885PTGS1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback